Why does inhibiting aldosterone synthesis reduce blood pressure in hypertension, even when angiotensin II levels remain high?

💡 Explanation

Inhibiting aldosterone synthesis reduces blood pressure because it directly limits sodium reabsorption in the kidneys, preventing fluid retention and subsequent blood volume expansion. Therefore, blood pressure decreases, rather than changes in arterial stiffness or direct baroreceptor modulation.

• Following an emergency transfusion with mismatched ABO blood type, which physiological effect dominates in a patient exhibiting acute hemolytic transfusion reaction due to antibody-antigen incompatibility?
• If chronic insulin resistance develops despite sufficient insulin secretion from pancreatic beta cells, which cellular mechanism explains why circulating glucose levels remain elevated, particularly affecting GLUT4-dependent tissues?
• What happens to the volume of red blood cells when a patient receives an intravenous infusion of hypertonic saline solution?
• If a pharmaceutical company aims to reduce inflammation by targeting the NF-κB signaling pathway, which consequence involving cytokine production is most likely?
• Why does liver damage due to chronic alcohol consumption elevate blood ammonia levels?
• During weightlifting, a lifter strains to complete a bench press rep. Which failure mode becomes likely when the force demands exceed the biomechanical limits of the shoulder joint?